World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
8048
World Ranking
18069
National Ranking
219

Yong Chul Kim publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Yong Chul Kim sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 219 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Yong Chul Kim D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Yong Chul Kim sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 49 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Yong Chul Kim is affiliated with the Gwangju Institute of Science and Technology in South Korea. Their research activity is situated primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, contributing extensively to both areas through numerous publications.

The main subfields of Kim's work include Molecular Biology, Organic Chemistry, Physiology, Hematology, and Genetics. These domains align closely with the focused topics covered in their research outputs, which encompass Adenosine and Purinergic Signaling, Acute Myeloid Leukemia Research, Pharmacological Receptor Mechanisms and Effects, Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Chronic Myeloid Leukemia Treatments, and Quinazolinone synthesis and applications.

Kim's publication record shows frequent contributions to several key scientific journals. Notably, they have published multiple papers in the Journal of Medicinal Chemistry and the European Journal of Medicinal Chemistry. Other venues include Pharmaceuticals, UNC Libraries, and Bioorganic & Medicinal Chemistry Letters, reflecting a broad engagement with medicinal chemistry and pharmaceutical sciences.

Their recent published research includes the following papers:

  • Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m6A Methylation of RNA in Acute Myeloid Leukemia Cells, 2022, Pharmaceuticals
  • Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives, 2021, Journal of Medicinal Chemistry
  • Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia, 2020, European Journal of Medicinal Chemistry
  • AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists, 2022, European Journal of Medicinal Chemistry
  • Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents, 2021, Journal of Medicinal Chemistry

Collaboration is a discernible aspect of Kim's research environment, frequently co-authoring papers with several experts including Pyeonghwa Jeong, Koon Mook Kang, Je-Heon Lee, Mi Sun Jin, and Sun-Young Han.

Best Publications

  • Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

    Yong-Chul Kim;Xiao-duo Ji;Neli Melman;Joel Linden

  • Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS15943) Are Selective for the Human A3 Receptor Subtype

    Yong-Chul Kim;Xiao-duo Ji;Kenneth A. Jacobson

  • Structure–activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists

    Kwan-Young Jung;Soo-Kyung Kim;Zhan-Guo Gao;Ariel S Gross

  • MIPs are ancestral ligands for the sex peptide receptor

    Young-Joon Kim;Katarina Bartalska;Neil Audsley;Naoki Yamanaka

  • Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.

    Kenneth A. Jacobson;Kyung-Sun Park;Ji-Long Jiang;Yong-Chul Kim

  • A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor

    Qiaoling Jiang;Danping Guo;Brian X. Lee;A. Michiel Van Rhee

  • Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities

    Myoung Ju Moon;Sang Kook Lee;Jong-Won Lee;Woo Keun Song

  • Activation of ATM depends on chromatin interactions occurring before induction of DNA damage

    Yong-Chul Kim;Gabi Gerlitz;Takashi Furusawa;Frédéric Catez

  • A novel flavin-containing monooxygenase from Methylophaga sp strain SK1 and its indigo synthesis in Escherichia coli.

    Hack Sun Choi;Jin Kwon Kim;Eun Hee Cho;Yong Chul Kim

  • FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.

    Tae In Kam;Sungmin Song;Youngdae Gwon;Hyejin Park

  • Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells.

    Yunjo Soh;Kyu-Shik Jeong;Insong James Lee;Myung-Ae Bae

  • ADENOSINE A3 RECEPTOR AGONISTS PROTECT HL-60 AND U-937 CELLS FROM APOPTOSIS INDUCED BY A3 ANTAGONISTS

    Yao Yao;Yoshitatsu Sei;Maria P. Abbracchio;Ji-Long Jiang

  • Subdermal Flexible Solar Cell Arrays for Powering Medical Electronic Implants.

    Kwangsun Song;Jung Hyun Han;Taehoon Lim;Namyun Kim

  • Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.

    Sung Tae Yang;Song Yub Shin;Chul Won Lee;Yong Chul Kim

  • Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

    Y C Kim;M de Zwart;L Chang;S Moro

  • Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis

    Cho-Rong Lee;Yewon Kwak;Taewoo Yang;Jung Hyun Han

  • Structure-Activity Relationships of Pyridoxal Phosphate Derivatives as Potent and Selective Antagonists of P2X1 Receptors

    Kim Yc;Brown Sg;Harden Tk;Boyer Jl

  • Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo

    Huiling Hu;Wennan Lu;Mei Zhang;Xiulan Zhang

  • [3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors

    Xiao-duoseqkat Ji;Yong-Chul Kim;David G Ahern;Joel Linden

  • Pharmacological characterization of novel A 3 adenosine receptor-selective antagonists

    Kenneth A. Jacobson;Kyung-Sun Park;Ji-Long Jiang;Yong-Chul Kim

Frequent Co-Authors

Kenneth A. Jacobson
Kenneth A. Jacobson National Institutes of Health
Sang Kook Lee
Sang Kook Lee Seoul National University
Stefano Moro
Stefano Moro University of Padua
José L. Boyer
José L. Boyer Inspire Pharmaceuticals
Lak Shin Jeong
Lak Shin Jeong Seoul National University
Geoffrey Burnstock
Geoffrey Burnstock University College London
T. Kendall Harden
T. Kendall Harden University of North Carolina at Chapel Hill
Joel Linden
Joel Linden University of Virginia
Sangyong Jon
Sangyong Jon Korea Advanced Institute of Science and Technology
Tae Sung Kim
Tae Sung Kim Korea University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Yong Chul Kim

Trending Scientists

Recently Published Articles